Author:
Michaelis Martin,Agha Bishr,Rothweiler Florian,Löschmann Nadine,Voges Yvonne,Mittelbronn Michel,Starzetz Tatjana,Harter Patrick N.,Abhari Behnaz A.,Fulda Simone,Westermann Frank,Riecken Kristoffer,Spek Silvia,Langer Klaus,Wiese Michael,Dirks Wilhelm G.,Zehner Richard,Cinatl Jaroslav,Wass Mark N.,Cinatl Jindrich
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Mukhopadhyay, T., Sasaki, J., Ramesh, R. & Roth, J. A. Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin Cancer Res. 8, 2963–2969 (2002).
2. Spagnuolo, P. A. et al. The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myeloma. Blood 115, 4824–4833 (2010).
3. Sasaki, J. et al. The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells. Mol. Cancer Ther. 1, 1201–1209 (2002).
4. Doudican, N., Rodriguez, A., Osman, I. & Orlow, S. J. Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Mol. Cancer Res. 6, 1308–1315 (2008).
5. Martarelli, D., Pompei, P., Baldi, C. & Mazzoni, G. Mebendazole inhibits growth of human adrenocortical carcinoma cell lines implanted in nude mice. Cancer Chemother. Pharmacol. 61, 809–817 (2008).
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献